Objectives. This study aimed to compare the characteristics of fully and partially vaccinated or unvaccinated coronavirus disease 2019 (COVID-19) patients who were hospitalised in a population of 220,000 habitants. Methods: Retrospective, observational, and population studies were conducted on patients who were hospitalised due to COVID-19 from March to October 2021. We assessed the impact of vaccination and other risk factors through Cox multivariate analysis. Results: A total of 500 patients were hospitalised, among whom 77 (15.4%) were fully vaccinated, 86 (17.2%) were partially vaccinated, and 337 (67.4%) were unvaccinated. Fully vaccinated (FV) patients were older and had a higher Charlson index than those of partially vaccinated and u...
Since December 2019, the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) pandemic has ...
The clinical trials of the COVID-19 vaccines that are authorized in the European Union have revealed...
The vaccination campaign and the new SARS-CoV-2 variants may have changed the clinical profile and o...
ObjectiveThere is a probability that vaccination may lead to reduction in the severity and complicat...
Background: Several descriptive cohort studies of patients affected by COVID-19 have been published....
Romania has a poor uptake of COVID-19 vaccination in its population. The study objectives were to ev...
Background: Individuals vaccinated against severe acute respiratory syndrome coronavirus 2 (SARS-CoV...
Old age is one of the most important risk factors for severe COVID-19. Few studies have analyzed cha...
With the emergence of SARS-CoV-2, influenza surveillance systems in Spain were transformed into a ne...
(1) Background: The development of effective COVID-19 vaccines has reduced the impact of COVID-19 on...
Background: The aim of this study was to analyze the percentage of patients admitted to the ICU havi...
Objective: Vaccination against severe acute respiratory syndrome coronavirus-2 (SARS-2) prevents the...
: The objective of our study was to determine the joint protective effect of a previous SARS-CoV-2 i...
Background: The country of Spain has one of the highest incidences of COVID-19, with more than 1,000...
Since December 2019, the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) pandemic has ...
Since December 2019, the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) pandemic has ...
The clinical trials of the COVID-19 vaccines that are authorized in the European Union have revealed...
The vaccination campaign and the new SARS-CoV-2 variants may have changed the clinical profile and o...
ObjectiveThere is a probability that vaccination may lead to reduction in the severity and complicat...
Background: Several descriptive cohort studies of patients affected by COVID-19 have been published....
Romania has a poor uptake of COVID-19 vaccination in its population. The study objectives were to ev...
Background: Individuals vaccinated against severe acute respiratory syndrome coronavirus 2 (SARS-CoV...
Old age is one of the most important risk factors for severe COVID-19. Few studies have analyzed cha...
With the emergence of SARS-CoV-2, influenza surveillance systems in Spain were transformed into a ne...
(1) Background: The development of effective COVID-19 vaccines has reduced the impact of COVID-19 on...
Background: The aim of this study was to analyze the percentage of patients admitted to the ICU havi...
Objective: Vaccination against severe acute respiratory syndrome coronavirus-2 (SARS-2) prevents the...
: The objective of our study was to determine the joint protective effect of a previous SARS-CoV-2 i...
Background: The country of Spain has one of the highest incidences of COVID-19, with more than 1,000...
Since December 2019, the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) pandemic has ...
Since December 2019, the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) pandemic has ...
The clinical trials of the COVID-19 vaccines that are authorized in the European Union have revealed...
The vaccination campaign and the new SARS-CoV-2 variants may have changed the clinical profile and o...